Published in
BioMed Central, Breast Cancer Research, 6(13), 2011
DOI: 10.1186/bcr3077
Links
- ORCID
- ORCID
- BioMed Central | PDF
- Crossref | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [dugi-doc.udg.edu] | PDF
- [ddd.uab.cat] | PDF
- [europepmc.org] | PDF
- [dugi-doc.udg.edu] | PDF
Tools
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines
Journal article published in 2011 by
Teresa Puig,
Helena Aguilar,
Sílvia Cufí,
Glòria Oliveras,
Carlos Turrado,
Sílvia Ortega-Gutiérrez 
,
Bellinda Benhamú,
María Luz López-Rodríguez ,
Ander Urruticoechea,
Ramon Colomer
,
Bellinda Benhamú,
María Luz López-Rodríguez ,
Ander Urruticoechea,
Ramon Colomer
This paper is made freely available by the publisher.
Full text: Download
Data provided by 